About Premas Life Sciences Private Limited
Data last updated:
Premas Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 15 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2011PTC217592. Its GSTIN is 07AAGCP0079F1ZI (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹28.73 Cr. It is led by directors including Praveen Kumar Gupta (Managing Director) and Debjit Patra.
Its last annual general meeting (AGM) was held on 28 August 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Second Floor E – 49/5 Okhla Industrial Estate Phase – II, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹309.66 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹39.88 Cr (net margin 12.9%) and EBITDA of ₹56.36 Cr (EBITDA margin 18.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 29% over five years.
The company has about 88 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Premas Life Sciences. As per MCA filings, the company has open charges of ₹132 Cr on record. Court records list 11 cases involving the company, including 11 filed by the company; 1 case is pending. The company has 6 deals on record (3 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹50,000; the latest was in April 2021. Its 7 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Mankind Prime Labs Private Limited with revenue of ₹332.48 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premaslifesciences.com.
Company details
Contact details
Premas Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its website is premaslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSecond Floor E – 49/5 Okhla Industrial Estate Phase – II, New Delhi, Delhi, India – 110020
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Premas Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Premas Life Sciences operates one associated brand: Premas Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Distributes cutting-edge genomics tools for research, clinical diagnostics, and biotechnology applications. | premaslifesciences.com |
Business activity
The main business activities of Premas Life Sciences are trade and professional, scientific and technical. In detail, this covers wholesale trading and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Premas Life Sciences Private Limited, buy the company report.
Financials of Premas Life Sciences Private Limited
FY 2024 filings availablePremas Life Sciences Private Limited reported revenue of ₹309.66 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.88 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.2% | ||||
| Net Profit Margin | 12.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Premas Life Sciences Private Limited, buy the company report.
Board of directors and KMP of Premas Life Sciences Private Limited
Premas Life Sciences Private Limited currently reports 3 directors and 1 key managerial person. 3 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Debjit Patra | Director | 20 Mar 2016 | 10 Years 7 Months | Current |
| Praveen Kumar Gupta | Managing Director | 15 Apr 2011 | 15 Years 6 Months | Current |
| Ashok Jain | Cfo | 09 Sep 2022 | 4 Years 1 Months | Current |
| Avijit Das | Director | 15 Apr 2011 | 15 Years 6 Months | Current |
Peer comparison
Premas Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mankind Prime Labs Private Limited | ₹332.48 Cr (FY 2025) | 29.0% | New Delhi, Delhi, India | |||
| Konica Minolta Healthcare India Private Limited | ₹332.02 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Innvolution Healthcare Private Limited | ₹323.31 Cr (FY 2025) | 13.0% | Bangalore, Karnataka, India | |||
| Avik Televentures Private Limited | ₹322.36 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Premas Life Sciences Private Limitedthis company | ₹309.66 Cr (FY 2025) | ₹39.88 Cr | 12.9% | -2.0% | 88 | New Delhi, Delhi, India |
| Chhattisgarh Medical Services Corporation Limited | ₹305.27 Cr (FY 2019) | 17.0% | Raipur, Chhattisgarh, India | |||
| My Healthskape Medicals Private Limited | ₹289.49 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Impex Healthcare Private Limited | ₹283.06 Cr (FY 2025) | -27.0% | New Delhi, Delhi, India |
To see the full peer comparison of Premas Life Sciences Private Limited, buy the company report.
Auditor
Premas Life Sciences Private Limited is audited by R R Bajaj & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R R Bajaj & Associates | FY 2023 | 100895W |
Shareholding
The shareholding of Premas Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Premas Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2021 | 100535456 | Others | ₹27 Cr | Open | |
| 29 Nov 2021 | 100504820 | Hdfc Bank Limited | ₹80 Cr | Open | |
| 14 Mar 2019 | 100271765 | Citi Bank N.A. | ₹25 Cr | Open |
To see the full charge records of Premas Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Premas Life Sciences Private Limited has 6 deals on record (3 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹50,000; the latest was in April 2021.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2021 | Rights issue | ₹18 Lakh | Investors: 4 individuals |
| Jan 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2016 | Funding round | ₹50,000 | Investors: an individual |
| Apr 2016 | Rights issue | ₹28.3 Lakh | Investors: New Horizon Technology Llc, Golden Bay Nz Trust, 2 individuals |
| Feb 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Premas Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Premas Life Sciences Private Limited has 11 court cases on record: 11 filed by Premas Life Sciences. 1 case is pending and 10 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 0 |
| High courts | 4 | 0 | 1 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Civil suit | Filed by the company against NMC Genetics India Pvt Ltd | Disposed |
| District court, South East, Delhi | Execution petition | Filed by the company against NMC Genetics India Pvt. Ltd. | Disposed |
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against Clevergene Biocorp Pvt Ltd | Disposed |
| District court, South East, Delhi | Commercial suit | Filed by the company against Arrow Labs Pvt. Ltd. | Disposed |
| High Court, JHARKHAND | Writ petition | Filed by the company against The State of Jharkhand and 2 others | Pending |
To see the full case history of Premas Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Premas Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Premas Life Sciences Private Limited has a workforce of 88 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Premas Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCP0079F1ZI | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Premas Life Sciences Private Limited, buy the company report.
Recent activity
Premas Life Sciences Private Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Ashok Jain was appointed as CFO on 09 Sep 2022.
4 earlier events are in the company report.
News
Frequently asked questions
Premas Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 15 April 2011 (15+ years old) and is registered under CIN U51909DL2011PTC217592.
Premas Life Sciences has 4 current directors and KMP:
- Praveen Kumar Gupta - Managing Director
- Debjit Patra - Director
- Avijit Das - Director
- Ashok Jain - Cfo
The latest financial statements of Premas Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 August 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Premas Life Sciences is 07AAGCP0079F1ZI, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Premas Life Sciences is U51909DL2011PTC217592. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Premas Life Sciences has 11 court cases on record: 11 filed by the company. 1 is pending. Most are in the district courts.
Premas Life Sciences was incorporated on 15 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Premas Life Sciences has 6 deals on record (3 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹50,000; the latest was in April 2021.
The peers of Premas Life Sciences by revenue are Mankind Prime Labs Private Limited, Konica Minolta Healthcare India Private Limited, Innvolution Healthcare Private Limited, Avik Televentures Private Limited, Chhattisgarh Medical Services Corporation Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Ashok Jain was appointed as CFO on 09 Sep 2022. Praveen Kumar Gupta ceased to be Director on 17 Jul 2018. Debjit Patra ceased to be Additional Director on 24 Sep 2016. Premas Life Sciences has 7 board changes on record in total.
Premas Life Sciences can be reached through the website premaslifesciences.com. Its registered office is in New Delhi, Delhi, India.